![](/img/cover-not-exists.png)
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
Pegram, M D, Lipton, A, Hayes, D F, Weber, B L, Baselga, J M, Tripathy, D, Baly, D, Baughman, S A, Twaddell, T, Glaspy, J A, Slamon, D JVolume:
16
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1998.16.8.2659
Date:
August, 1998
File:
PDF, 1.12 MB
english, 1998